How often do patient insights actually change what an organisation does next?
If your answer is ‘hard to know’ then that’s a problem – but you’re not alone. Measuring the impact of patient engagement is notoriously tricky. Outcomes are often long term, much of the value is captured qualitatively, and different stakeholders perceive patient engagement-derived value in different ways. While comprehensive tools exist – such as the PFMD Metrics Selector, with more than 100 potential metrics – they can easily overwhelm rather than clarify.
At a recent patient engagement conference, one point of convergence stood out: track how patient insights actually influence decisions, priorities and actions across the organisation. For senior patient advocacy leaders, this reflects a broader reality. Demonstrating the value of patient engagement internally now demands much more than high levels of activity, but rather evidence of influence. From a patient perspective, this is equally critical, as it shows that lived experience is driving meaningful organisational change and shaping how medicines are developed.
Academic literature and established evaluation frameworks consistently highlight the need to move beyond volume and satisfaction metrics towards indicators that capture learning, decision making and organisational behaviour change. Measuring influence recognises that patient engagement is not an endpoint, but a catalyst – shaping choices, accelerating alignment and unblocking progress across the organisation.
This is not to suggest that influence alone should be the sole focus of evaluating patient engagement. Evaluation must be anchored to strategy. Mapping potential indicators against an organisation’s patient engagement objectives helps ensure that what is measured truly matters. In practice, this means considering three complementary layers: process indicators, outcome indicators and impact indicators.
Critically, prioritisation counts. Rather than tracking everything, we work with our clients to align cross-functional teams – and patient partners themselves – around a focused set of measurable indicators that accurately reflect the strategy. These become shared markers of progress, enabling patient engagement to be understood not only as the right thing to do, but as a powerful creator of organisational momentum.
